ELTP (Elite Pharmaceuticals) Inventory Turnover: 0.86 (As of Dec. 2025)

What is Elite Pharmaceuticals Inventory Turnover?

Elite Pharmaceuticals ELTP -0.03% 44 Inventory Turnover is 0.86 as of Dec. 2025. GuruFocus rates ELTP with a GF Score™ of 44/100 and a GF Value™ of $0.57 (Possible Value Trap). The stock has 1 warning sign investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Elite Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2025 was $18.6 Mil. Elite Pharmaceuticals's Average Total Inventories for the quarter that ended in Dec. 2025 was $21.6 Mil. Elite Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.86.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Elite Pharmaceuticals's Days Inventory for the three months ended in Dec. 2025 was 105.92.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Elite Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.68.

Elite Pharmaceuticals (OTCPK:ELTP) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Elite Pharmaceuticals's Days Inventory for the three months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	21.632	/	18.636	*	365 / 4
	=	105.92

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Elite Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	21.632	/	31.589
	=	0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Elite Pharmaceuticals Inventory Turnover Related Terms

Elite Pharmaceuticals Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Elite Pharmaceuticals's Inventory Turnover can be seen below:

Elite Pharmaceuticals Inventory Turnover Chart

Elite Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Inventory Turnover

Get a 7-Day Free Trial

2.95

2.97

2.16

2.69

3.01

Elite Pharmaceuticals Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															0.48	0.81	0.73	1.19	0.86

44GF Score

Elite Pharmaceuticals Inc ELTP

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Elite Pharmaceuticals Inventory Turnover Calculation

Elite Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Mar. 2025 is calculated as

	Inventory Turnover (A: Mar. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Mar. 2025 )	/ (	(Total Inventories (A: Mar. 2024 )	+	Total Inventories (A: Mar. 2025 ))	/	count )
=	43.957	/ (	(12.93	+	16.24)	/	2 )
=	43.957	/	14.585
=	3.01

Elite Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Sep. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	18.636	/ (	(18.165	+	25.099)	/	2 )
=	18.636	/	21.632
=	0.86

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.86 mean?

Elite Pharmaceuticals (ELTP) has a Inventory Turnover of 0.86 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Elite Pharmaceuticals and its competitors.

Is Elite Pharmaceuticals' Inventory Turnover too high?

Elite Pharmaceuticals' current Inventory Turnover is 0.86. Overall, Elite Pharmaceuticals has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Elite Pharmaceuticals' Inventory Turnover compare to EBS and NIKA?

Elite Pharmaceuticals' Inventory Turnover of 0.86 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Elite Pharmaceuticals and its competitors. Elite Pharmaceuticals's current Inventory Turnover is 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Elite Pharmaceuticals stock overvalued right now?

Based on GuruFocus' analysis, Elite Pharmaceuticals (ELTP) is currently considered Possible Value Trap. The stock's GF Value™ is $0.57, compared to a current price of $0.40 — trading 30.7% below its estimated fair value. The current Inventory Turnover is 0.86. Elite Pharmaceuticals' overall GF Score™ is 44/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Elite Pharmaceuticals (ELTP), the current Inventory Turnover is 0.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elite Pharmaceuticals (ELTP) Overvalued in 2026?

Based on GuruFocus' analysis, Elite Pharmaceuticals stock appears to be undervalued. The current stock price of $0.40 is trading 30.7% below its estimated GF Value™ of $0.57. GuruFocus considers Elite Pharmaceuticals to be Possible Value Trap.

Key valuation signals for ELTP:

Inventory Turnover: 0.86
GF Value™: $0.57 vs. price of $0.40 (30.7% below fair value)
GF Score™: 44/100 with 1 warning sign

No single metric tells the full story. See the ELTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elite Pharmaceuticals Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies EBS NIKA EOLS ORGO TKNO AKBA AQST TLRY SIGA ANIK XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Address 165 Ludlow Avenue, Northvale, NJ, USA, 07647

Website https://www.elitepharma.com

Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.

44GF Score

Get the complete analysis for ELTP

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40

Price

$0.57

GF Value

View ELTP Analysis

See Inventory Turnover data for all stocks →